We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · November 22, 2021

Incidence and Risk Factors for Herpes Zoster in Patients With Rheumatoid Arthritis Receiving Upadacitinib

Annals of the Rheumatic Diseases

 

Additional Info

Annals of the Rheumatic Diseases
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials
Ann. Rheum. Dis 2021 Oct 06;[EPub Ahead of Print], KL Winthrop, P Nash, K Yamaoka, E Mysler, N Khan, HS Camp, Y Song, JL Suboticki, JR Curtis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading